{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:41:07Z","timestamp":1791222067221,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jcyt.2024.12.004","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T12:10:22Z","timestamp":1734437422000},"page":"465-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Outcomes of allogeneic hematopoietic stem cell transplantation in Shwachman-Diamond syndrome: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Cuiping","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengqin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaodan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8484-3731","authenticated-orcid":false,"given":"Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.12.004_bib0001","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.hoc.2018.04.006","article-title":"Diagnosis, treatment, and molecular pathology of Shwachman-Diamond syndrome","volume":"32","author":"Nelson","year":"2018","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0002","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1182\/blood.2022017739","article-title":"Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances","volume":"141","author":"Reilly","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0003","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.3324\/haematol.2023.282949","article-title":"Shwachman-Diamond syndromes: clinical, genetic, and biochemical insights from the rare variants","volume":"108","author":"Kawashima","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0004","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1038\/s41409-020-0863-z","volume":"55","author":"Cesaro","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0005","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2352-3026(19)30206-6","article-title":"Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study","volume":"7","author":"Myers","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0006","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0008","series-title":"Kendall's advanced theory of statistics","author":"Stuart","year":"1994"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0009","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3324\/haematol.2011.057489","article-title":"Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome","volume":"97","author":"Donadieu","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation","volume":"376","author":"Lindsley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0011","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.bbmt.2014.08.020","article-title":"Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial","volume":"20","author":"Burroughs","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0012","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.2005.05758.x","article-title":"Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation","volume":"131","author":"Cesaro","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0013","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1182\/bloodadvances.2021005539","article-title":"Hematologic complications with age in Shwachman-Diamond syndrome","volume":"6","author":"Furutani","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0014","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.bbmt.2020.04.029","article-title":"Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome","volume":"26","author":"Myers","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpeds.2019.12.041","article-title":"A prospective study of hematologic complications and long-term survival of Italian patients affected by Shwachman-Diamond syndrome","volume":"219","author":"Cesaro","year":"2020","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0016","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.bbmt.2017.06.002","article-title":"Allogeneic hematopoietic cell transplantation using treosulfan-based conditioning for treatment of marrow failure disorders","volume":"23","author":"Burroughs","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0017","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1399-0004.2010.01468.x","article-title":"Comparative analysis of Shwachman-Diamond syndrome to other inherited bone marrow failure syndromes and genotype-phenotype correlation","volume":"79","author":"Hashmi","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0018","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3324\/haematol.2010.027839","article-title":"Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemia","volume":"96","author":"Bizzetto","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0019","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bmt.1705553","article-title":"Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome","volume":"39","author":"Sauer","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.bmt.1705141","article-title":"Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry","volume":"36","author":"Donadieu","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0021","unstructured":"National Institute of Health. Quality assessment tool for before-after (pre-post) studies with no control group. Accessed June 2024. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"issue":"7","key":"10.1016\/j.jcyt.2024.12.004_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29071","article-title":"Shwachman-Diamond syndrome and solid tumors: three new patients from the French Registry for Severe Chronic Neutropenia and literature review","volume":"68","author":"Bou Mitri","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0023","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jtct.2022.07.010","article-title":"Stem cell transplantation in patients affected by shwachman-diamond syndrome: expert consensus and recommendations from the EBMT Severe Aplastic Anaemia Working Party","volume":"28","author":"Cesaro","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0024","first-page":"103423","article-title":"Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","volume":"71","author":"Cuccuini","year":"2023","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0025","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2017-08-801985","article-title":"Somatic mutations and clonal hematopoiesis in congenital neutropenia","volume":"131","author":"Xia","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0026","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/bmt.2017.46","article-title":"First experience of hematopoietic stem cell transplantation treatment of Shwachman-Diamond syndrome using unaffected HLA-matched sibling donor produced through preimplantation HLA typing","volume":"52","author":"Isaev","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.bmt.1703321","article-title":"Successful allogeneic hematopoietic stem cell transplantation (HSCT) for Shwachman-Diamond syndrome","volume":"29","author":"Fleitz","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0028","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2008.151","article-title":"Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome","volume":"42","author":"Bhatla","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0029","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and Myelodysplastic Syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0030","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/bloodadvances.2018021980","article-title":"Hematopoietic cell transplant for acute myeloid leukemia and myelodysplastic syndrome: conditioning regimen intensity","volume":"2","author":"Eapen","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0031","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0032","doi-asserted-by":"crossref","first-page":"68.e1","DOI":"10.1016\/j.bbmt.2020.09.026","volume":"27","author":"Bejanyan","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0033","doi-asserted-by":"crossref","first-page":"323.e1","DOI":"10.1016\/j.jtct.2022.03.011","article-title":"Myeloablative versus reduced-intensity conditioning with fludarabine\/busulfan for myelodysplastic syndrome: a propensity score-matched analysis","volume":"28","author":"Kurosawa","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0034","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0035","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2033122","article-title":"Ruxolitinib for glucocorticoid-refractory chronic graft-versus-host disease","volume":"385","author":"Zeiser","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0036","article-title":"Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease","author":"Mahmoudjafari","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0037","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1097\/MJT.0000000000001639","article-title":"Unique pharmacokinetics for oral tacrolimus administration after allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia with Shwachman-Diamond syndrome","volume":"31","author":"Inoue","year":"2024","journal-title":"Am J Ther"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0038","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-024-06060-9","article-title":"Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasms","author":"Min","year":"2024","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0039","doi-asserted-by":"crossref","first-page":"1059569","DOI":"10.3389\/fped.2022.1059569","article-title":"Case report: Venetoclax therapy in a boy with acute myeloid leukemia in Shwachman Diamond syndrome","volume":"10","author":"Naviglio","year":"2023","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0040","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/CAD.0000000000001594","article-title":"Azacitidine combined with venetoclax alleviates AML-MR with TP53 mutation in SDS: a case report and literature review","volume":"35","author":"Ma","year":"2024","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.jcyt.2024.12.004_bib0041","doi-asserted-by":"crossref","first-page":"h4718","DOI":"10.1136\/bmj.h4718","article-title":"How to read a funnel plot in a meta-analysis","volume":"351","author":"Sedgwick","year":"2015","journal-title":"BMJ"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924009472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924009472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T20:09:47Z","timestamp":1762546187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924009472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1465324924009472"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.12.004","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of allogeneic hematopoietic stem cell transplantation in Shwachman-Diamond syndrome: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}